EyeGene, Inc.
No trades
−512 KRW
−15.71 B KRW
3.57 B KRW
30.64 M
About EyeGene, Inc.
Sector
Industry
CEO
Suk-Keun Choi
Website
Headquarters
Uiwang-si
Founded
2000
IPO date
Nov 16, 2015
Identifiers
2
ISIN KR7185490000
Eyegene, Inc. engages in the provision of research and development of pharmaceutical products. Its products include curing technologies and vaccines for diabetic retinopathy, decubitus ulcer, cervical cancer, and adjuvant immunotherapy. The company was founded on June 23, 2000 and is headquartered in Uiwang-si, South Korea.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of 185490 is 1,454 KRW — it has decreased by −1.76% in the past 24 hours. Watch EyeGene, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange EyeGene, Inc. stocks are traded under the ticker 185490.
185490 stock has fallen by −14.92% compared to the previous week, the month change is a 8.91% rise, over the last year EyeGene, Inc. has showed a −47.16% decrease.
185490 reached its all-time high on Sep 1, 2021 with the price of 51,523 KRW, and its all-time low was 1,182 KRW and was reached on Mar 4, 2026. View more price dynamics on 185490 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
185490 stock is 7.68% volatile and has beta coefficient of 0.24. Track EyeGene, Inc. stock price on the chart and check out the list of the most volatile stocks — is EyeGene, Inc. there?
Today EyeGene, Inc. has the market capitalization of 63.97 B, it has decreased by −8.05% over the last week.
Yes, you can track EyeGene, Inc. financials in yearly and quarterly reports right on TradingView.
185490 net income for the last quarter is −3.45 B KRW, while the quarter before that showed −8.83 B KRW of net income which accounts for 0.00% change. Track more EyeGene, Inc. financial stats to get the full picture.
No, 185490 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 9, 2026, the company has 49 employees. See our rating of the largest employees — is EyeGene, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EyeGene, Inc. EBITDA is −8.89 B KRW, and current EBITDA margin is −220.29%. See more stats in EyeGene, Inc. financial statements.
Like other stocks, 185490 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EyeGene, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EyeGene, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EyeGene, Inc. stock shows the sell signal. See more of EyeGene, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.